Form 8-K - Current report:
SEC Accession No. 0001193125-25-046225
Filing Date
2025-03-05
Accepted
2025-03-05 07:08:25
Documents
19
Period of Report
2025-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d940326d8k.htm   iXBRL 8-K 39812
2 EX-4.1 d940326dex41.htm EX-4.1 64610
3 EX-10.1 d940326dex101.htm EX-10.1 230693
4 EX-10.2 d940326dex102.htm EX-10.2 52971
5 EX-99.1 d940326dex991.htm EX-99.1 10171
9 GRAPHIC g940326g0305084717581.jpg GRAPHIC 4788
10 GRAPHIC g940326g65g66.jpg GRAPHIC 10414
  Complete submission text file 0001193125-25-046225.txt   652049

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA calc-20250228.xsd EX-101.SCH 2876
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE calc-20250228_lab.xml EX-101.LAB 18736
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE calc-20250228_pre.xml EX-101.PRE 11724
22 EXTRACTED XBRL INSTANCE DOCUMENT d940326d8k_htm.xml XML 3805
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39538 | Film No.: 25708804
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)